We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Free Mallinckrodt Drugs Risk Kickback Fines, Watchdog Says

Law360 (November 19, 2018, 9:42 PM EST) -- Mallinckrodt PLC could face Anti-Kickback Statute sanctions under its plan to offer free vials of anti-seizure drug H.P. Acthar Gel, the Office of Inspector General for the U.S. Department of Health...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.